Belgian consensus for Helicobacter pylori management 2023.

INTRODUCTION Helicobacter pylori (H. pylori) infection causes chronic gastritis, peptic ulcers and gastric cancer. Although H. pylori prevalence is decreasing worldwide, regional variations exist in Europe, with the lowest infection prevalence in Northern Europe, and the highest in Eastern and Southern Europe. Changes in the treatment recommendations and the increasing available evidence have justified the implementation of new recommendations since last Belgian consensus in 1998. Several non-H. pylori Helicobacter species (NH. PYLORI-H), colonizing the stomach of domestic animals, also have t... Mehr ...

Verfasser: Garcés-Duran, Rodrigo
Kindt, Sébastien
Kotilea, Kallirroi
François, Silke
Rasschaert, Gertjan
Smet, Annemieke
Hauser, Bruno
Driessen, Ann
Nkuize, Marcel
Burette, Alain
Lamy, Vincent
Bontems, Patrick
Louis, Hubert
Ntounda, Ruffin
Miendje Deyi, Véronique Y
Mana, Fazia
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Verlag/Hrsg.: Taylor & Francis
Schlagwörter: Humans / Helicobacter pylori / Consensus / Belgium / Helicobacter Infections / Anti-Bacterial Agents / diagnosis / recommendations / treatment
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27305786
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/286653

INTRODUCTION Helicobacter pylori (H. pylori) infection causes chronic gastritis, peptic ulcers and gastric cancer. Although H. pylori prevalence is decreasing worldwide, regional variations exist in Europe, with the lowest infection prevalence in Northern Europe, and the highest in Eastern and Southern Europe. Changes in the treatment recommendations and the increasing available evidence have justified the implementation of new recommendations since last Belgian consensus in 1998. Several non-H. pylori Helicobacter species (NH. PYLORI-H), colonizing the stomach of domestic animals, also have the ability to cause gastric disease in humans, although to a lesser extent. These zoonotic NH. PYLORIH are not the subject of the current recommendations. […]